Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114614) titled 'Fatty Acid Binding Proteins and Markers of Cellular Senescence in Cancer Survivors' on Aug. 4.
Study Type: Observational
Primary Sponsor: Case Comprehensive Cancer Center
Condition:
Marker
Structural
Intervention:
Other: Specimen #1
Recruitment Status: Not recruiting
Date of First Enrollment: August 2025
Target Sample Size: 120
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07114614
Published by HT Digital Content Services with permission from Health Daily Digest....